BD WavelinQ EndoAVF System for Kidney Disease

This study is looking at how well the BD® WavelinQ™ EndoAVF System works for people with kidney disease who need dialysis. This system helps create an arteriovenous (AV) fistula, which is a connection between an artery and a vein, usually in the arm, to make dialysis easier. You might be able to join if you are at least 18 years old and have kidney disease requiring dialysis. The study will check if the fistula works well for dialysis (functional cannulation success) and stays open (primary patency) after 6 months. It will also look at any serious problems related to the device or procedure within 30 days. The current recruitment status is unclear.

Study design
This is a single-arm study, meaning all participants will receive the same intervention. It plans to enroll 280 participants.
What's involved
You will have an endoAVF created using the WavelinQ EndoAVF System.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for at least 6 months after the procedure to check how well the fistula works.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT04634916

Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System

Recruiting
NAAges 18+InterventionalTreatment
C. R. Bard
~220 participants
Updated 2026-08-10 on ClinicalTrials.gov
What's tested:EndoAVF Creation

At a glance

Recruiting sites
15 of 17 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Functional Cannulation Success
Measured over 6-months post index procedure
+2 more outcomes measured
Kidney Disease, End-Stage
End-stage Renal Disease
Arteriovenous Fistula
17 sites across 10 states
Florida3
Massachusetts3
California2
Tennessee2
Texas2
New York1
North Carolina1
Ohio1
  • Eric Peden, MD · PRINCIPAL_INVESTIGATOR · The Methodist Hospital Research Institute
  • Paul Kreienberg, MD · PRINCIPAL_INVESTIGATOR · Albany Medical College

Opens a ready-to-send draft in your own email app — review before sending.

  • Functional Cannulation Success6-months post index procedure

    The percentage of subjects dialyzed using successful 2-needle access of the endoAVF for at least 75% of dialysis sessions over a continuous 28-day period

  • Primary Patency6-months post index procedure

    Subjects maintaining primary patency of the endoAVF

  • Device- and procedure-related serious adverse events (SAE)30-days post index procedure

    Freedom from device-related or procedure-related SAEs